Literature DB >> 21121552

Nongenital herpes simplex virus.

Richard P Usatine1, Rochelle Tinitigan.   

Abstract

Nongenital herpes simplex virus type 1 is a common infection usually transmitted during childhood via nonsexual contact. Most of these infections involve the oral mucosa or lips (herpes labialis). The diagnosis of an infection with herpes simplex virus type 1 is usually made by the appearance of the lesions (grouped vesicles or ulcers on an erythematous base) and patient history. However, if uncertain, the diagnosis of herpes labialis can be made by viral culture, polymerase chain reaction, serology, direct fluorescent antibody testing, or Tzanck test. Other nonoral herpes simplex virus type 1 infections include herpetic keratitis, herpetic whitlow, herpes gladiatorum, and herpetic sycosis of the beard area. The differential diagnosis of nongenital herpes simplex virus infection includes aphthous ulcers, acute paronychia, varicella-zoster virus infection, herpangina, herpes gestationis (pemphigoid gestationis), pemphigus vulgaris, and Behçet syndrome. Oral acyclovir suspension is an effective treatment for children with primary herpetic gingivostomatitis. Oral acyclovir, valacyclovir, and famciclovir are effective in treating acute recurrence of herpes labialis (cold sores). Recurrences of herpes labialis may be diminished with daily oral acyclovir or valacyclovir. Topical acyclovir, penciclovir, and docosanol are optional treatments for recurrent herpes labialis, but they are less effective than oral treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21121552

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  21 in total

1.  A Novel Thyroid Hormone Mediated Regulation of HSV-1 Gene Expression and Replication is Specific to Neuronal Cells and Associated with Disruption of Chromatin Condensation.

Authors:  Feng Chen; Jay Palem; Matthew Balish; Robert Figliozzi; Amakoe Ajavon; S Victor Hsia
Journal:  SOJ Pharm Pharm Sci       Date:  2014

2.  Paediatric recurrent herpetic whitlow.

Authors:  Ramnik Patel; Hemant Kumar; Bharat More; Mario Patricolo
Journal:  BMJ Case Rep       Date:  2013-07-31

3.  HSV-1 as well as HSV-2 is frequent in oral mucosal lesions of children on chemotherapy.

Authors:  Ritu Aggarwal; Deepak Bansal; Jasmine Naru; Manila Salaria; Anita Rana; Ranjana W Minz; Amita Trehan; R K Marwaha
Journal:  Support Care Cancer       Date:  2014-02-14       Impact factor: 3.603

Review 4.  Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics.

Authors:  Thessicar E Antoine; Paul J Park; Deepak Shukla
Journal:  Rev Med Virol       Date:  2013-02-26       Impact factor: 6.989

5.  Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.

Authors:  Brent Stanfield; Konstantin Gus Kousoulas
Journal:  Curr Clin Microbiol Rep       Date:  2015-07-01

6.  Effects of thyroid hormone on HSV-1 gene regulation: implications in the control of viral latency and reactivation.

Authors:  Shao-Chung Hsia; Gautam R Bedadala; Matthew D Balish
Journal:  Cell Biosci       Date:  2011-07-14       Impact factor: 7.133

Review 7.  Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.

Authors:  Mingxu Guan; Gaetano Romano; Roberta Coroniti; Earl E Henderson
Journal:  J Exp Clin Cancer Res       Date:  2014-11-01

8.  Nigerian Female with Skin Lesions in the Leg and Face: Herpetic Sycosis Folliculitis.

Authors:  Dominique Dilorenzo; Naganna Channaveeraiah; Patricia Gilford; Bruce Deschere
Journal:  Case Rep Infect Dis       Date:  2016-11-27

9.  Cutaneous infections in wrestlers.

Authors:  Eugene K Wilson; Kevin Deweber; James W Berry; John H Wilckens
Journal:  Sports Health       Date:  2013-09       Impact factor: 3.843

10.  Single dose of glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses.

Authors:  Arun V Iyer; Bapi Pahar; Vladimir N Chouljenko; Jason D Walker; Brent Stanfield; Konstantin G Kousoulas
Journal:  Virol J       Date:  2013-10-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.